CN111772185A - Plant health-care composition and preparation method thereof - Google Patents
Plant health-care composition and preparation method thereof Download PDFInfo
- Publication number
- CN111772185A CN111772185A CN202010571503.XA CN202010571503A CN111772185A CN 111772185 A CN111772185 A CN 111772185A CN 202010571503 A CN202010571503 A CN 202010571503A CN 111772185 A CN111772185 A CN 111772185A
- Authority
- CN
- China
- Prior art keywords
- parts
- drying
- ginseng
- plant health
- care composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 230000036541 health Effects 0.000 claims abstract description 39
- 238000001035 drying Methods 0.000 claims description 46
- 241000196324 Embryophyta Species 0.000 claims description 38
- 244000131316 Panax pseudoginseng Species 0.000 claims description 27
- 244000269722 Thea sinensis Species 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 18
- 235000008434 ginseng Nutrition 0.000 claims description 18
- 235000009569 green tea Nutrition 0.000 claims description 18
- 241000222336 Ganoderma Species 0.000 claims description 10
- 244000144730 Amygdalus persica Species 0.000 claims description 9
- 241000205585 Aquilegia canadensis Species 0.000 claims description 9
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 9
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 9
- 244000124209 Crocus sativus Species 0.000 claims description 9
- 235000015655 Crocus sativus Nutrition 0.000 claims description 9
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 9
- 240000005385 Jasminum sambac Species 0.000 claims description 9
- 240000000249 Morus alba Species 0.000 claims description 9
- 235000008708 Morus alba Nutrition 0.000 claims description 9
- 240000002853 Nelumbo nucifera Species 0.000 claims description 9
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 9
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 9
- 244000242564 Osmanthus fragrans Species 0.000 claims description 9
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims description 9
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 9
- 244000082204 Phyllostachys viridis Species 0.000 claims description 9
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 9
- 210000003056 antler Anatomy 0.000 claims description 9
- 239000011425 bamboo Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 240000008397 Ganoderma lucidum Species 0.000 claims description 8
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 244000241257 Cucumis melo Species 0.000 claims description 7
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 7
- 241000305491 Gastrodia elata Species 0.000 claims description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 7
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 7
- 235000013974 saffron Nutrition 0.000 claims description 7
- 239000004248 saffron Substances 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000013616 tea Nutrition 0.000 claims description 4
- 241000723345 Chrysophyllum Species 0.000 claims description 3
- 240000002624 Mespilus germanica Species 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 240000001548 Camellia japonica Species 0.000 claims description 2
- 241000675108 Citrus tangerina Species 0.000 claims description 2
- 241000305492 Gastrodia Species 0.000 claims description 2
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 240000007164 Salvia officinalis Species 0.000 claims description 2
- 235000018597 common camellia Nutrition 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 36
- 239000008280 blood Substances 0.000 abstract description 36
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001603 reducing effect Effects 0.000 abstract description 15
- 206010020772 Hypertension Diseases 0.000 abstract description 11
- 230000036772 blood pressure Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 10
- 235000012000 cholesterol Nutrition 0.000 abstract description 9
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 8
- 206010028980 Neoplasm Diseases 0.000 abstract description 7
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000002966 serum Anatomy 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000004614 tumor growth Effects 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 206010010774 Constipation Diseases 0.000 abstract description 2
- 230000010224 hepatic metabolism Effects 0.000 abstract description 2
- 230000003914 insulin secretion Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000011669 selenium Substances 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229910052732 germanium Inorganic materials 0.000 description 5
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960001214 clofibrate Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 230000008816 organ damage Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002115 aflatoxin B1 Substances 0.000 description 1
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 description 1
- 229930020125 aflatoxin-B1 Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000010351 cardiac pulsation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- -1 polysaccharide polyphenols Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 239000011802 pulverized particle Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a plant health-care composition and a preparation method thereof, and the health-care composition has unique and magical effects on reducing blood sugar, blood pressure and blood fat, diabetes and complications thereof, and has a synergistic balance regulation effect. The health care composition has obvious functions of reducing blood sugar and urine sugar and can effectively improve the three-high symptoms of diabetes. The health care composition can effectively reduce blood fat, improve various maladaptive symptoms caused by hypertension, reduce cholesterol and B-lipoprotein in serum, promote insulin secretion, enhance immunity, regulate blood flow, prevent atherosclerosis, resist bacteria, diminish inflammation, clear away heat and toxic materials, relieve constipation, promote diuresis, remove dampness, promote liver metabolism, prevent cancer, inhibit tumor growth and the like while effectively reducing blood sugar and blood pressure; the health care composition has simple preparation method and low production cost, and can be produced in a large scale.
Description
Technical Field
The invention belongs to the technical field of health care products, and particularly relates to a plant health care composition and a preparation method thereof.
Background
Hypertension, hyperglycemia and hyperlipidemia refer to hypertension, hyperglycemia and hyperlipidemia, the hypertension is one of the most common epidemic diseases in the present day, early-stage hypertension patients can show symptoms such as headache, dizziness, tinnitus, palpitation, dim eyesight, inattention, hypomnesis, numbness of hands and feet, fatigue, weakness, easy dysphoria and the like, the symptoms are mostly caused by higher nerve dysfunction, and the severity of the symptoms is inconsistent with the degree of increase of the blood pressure. The late stage blood pressure is always kept at a high level and is accompanied by the appearance of damaged organs such as brain, heart, kidney and the like. These organ damage can be either direct damage from hypertension or indirectly through accelerated development of atherosclerotic disease. The early stages of these organ damage can be asymptomatic, eventually leading to dysfunction and even failure. The most common hyperglycemia is diabetes. Diabetes is a chronic and lifelong disease, is a common disease seriously harming human health, and causes abnormal metabolism of nutrients such as carbohydrate, fat, protein and the like in vivo due to relative or absolute deficiency of insulin. The disease can cause various complications, and can cause systemic diseases when serious, which causes people to be disabled, blindness and even death. The symptoms of diabetes are "more than three and one less", i.e. polyuria, polydipsia, polyphagia and weight loss. Patients with hyperglycemia should pay attention to diet control, have low sugar and low salt content, strengthen exercise, and check blood sugar or high blood sugar again after a while, and also consider the drugs for reducing blood sugar. Hyperlipidemia refers to the condition of high blood cholesterol or triglyceride or low high-density lipoprotein cholesterol, and is called as dyslipidemia in modern medicine. If the blood fat is too high, blood viscosity is easily caused, the blood is deposited on the blood vessel wall, atherosclerosis is gradually formed, the blood vessel is gradually blocked, the blood flow is slowed down, and the blood flow is interrupted when the blood flow is serious.
At present, no good method and medicine for solving the three highs exist, great pain is brought to patients, and meanwhile, the later-period treatment cost is high.
The present invention has been made in view of the above circumstances.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a plant health-care composition and a preparation method thereof, and the plant health-care composition has unique magical effects of reducing blood sugar, blood pressure and blood fat, diabetes and complications thereof, and plays a role in synergistic balance regulation.
The invention provides a plant health-care composition, which is prepared from the following raw materials: wild ganoderma lucidum, ganoderma lucidum spore powder, ginseng under forest, pilose antler, saffron, cassia seed, medlar, pseudo-ginseng, tall gastrodia tuber, tangerine peel, red-rooted salvia root, cordyceps sinensis, honeysuckle flower, bamboo leaf, ginseng flower, jasmine flower, lotus leaf, peach flower, sweet osmanthus flower, mulberry leaf, golden camellia, Liuan melon slice, golden bud, Tieguanyin, Biluochun, Anji Maofeng, Longjing, Laoshan green tea, Gaoshan green tea, Houkui, pekoe green and Xinyang Maojian.
Further, the feed additive is prepared from the following raw materials in parts by weight: 2-4 parts of wild ganoderma lucidum, 0.3-0.7 part of ganoderma lucidum spore powder, 2-4 parts of ginseng under forest, 0.5-1.5 parts of pilose antler, 0.3-0.7 part of saffron crocus, 0.8-1.2 parts of cassia seed, 1-3 parts of wolfberry fruit, 2-4 parts of pseudo-ginseng, 1-3 parts of gastrodia elata, 1-3 parts of dried orange peel, 0.8-1.2 parts of salvia miltiorrhiza, 2-4 parts of cordyceps sinensis, 2-4 parts of honeysuckle, 2-4 parts of bamboo leaves, 1-3 parts of ginseng flower, 2-4 parts of jasmine flower, 1-3 parts of lotus leaf, 1-3 parts of peach blossom, 1-3 parts of sweet osmanthus flower, 1-3 parts of mulberry leaf, 2-4 parts of golden leaf, 3-5 parts of Liuan melon slice, 4-6 parts of golden bud, 6-10 parts of Tieguanyin, 3-5 parts of Biluochun spring, 4-6 parts of Anji Maofeng, 4-6 parts of Longjing, 3-5 parts of Laoshan green tea, 6-10 parts of Gaoshan green tea, 3-5 parts of Houkui, 3-5 parts of pekoe and 3-5 parts of Xinyang Maojian tea.
Further, the feed additive is prepared from the following raw materials in parts by weight: 3 parts of wild ganoderma, 0.5 part of ganoderma spore powder, 3 parts of ginseng under forest, 1 part of pilose antler, 0.5 part of saffron, 1 part of cassia seed, 2 parts of wolfberry fruit, 3 parts of pseudo-ginseng, 2 parts of gastrodia elata, 2 parts of dried orange peel, 1 part of salvia miltiorrhiza, 3 parts of cordyceps sinensis, 3 parts of honeysuckle, 3 parts of bamboo leaves, 2 parts of ginseng flowers, 3 parts of jasmine flowers, 2 parts of lotus leaves, 2 parts of peach blossom, 2 parts of sweet osmanthus, 2 parts of mulberry leaves, 3 parts of golden leaves, 4 parts of Liu' an melon slices, 5 parts of golden buds, 8 parts of Tieguanyin, 4 parts of Biluochun, 5 parts of Anji Maofeng, 5 parts of Longjing, 4 parts of Laoshan green tea, 8 parts of Gaoshan green tea, 4 parts of Houkui, 4 parts of Baihao green and 4 parts of.
The plant health composition of the invention is rich in trace elements such as germanium, selenium, zinc, cobalt, molybdenum, vanadium and the like, has important health care effect on human bodies, has obvious effects on regulating blood fat, blood sugar and cholesterol of the human bodies and enhancing the immunity of the organisms, can improve various uncomfortable symptoms caused by hypertension, and has the effects of resisting bacteria, diminishing inflammation, clearing away heat and toxic materials, inducing diuresis, reducing swelling, enhancing the vitality of livers and kidneys, preventing blood arteriosclerosis, preventing cancer, inhibiting tumor growth and the like. In addition, the health-care food also contains various beneficial components required by human bodies, such as various amino acids, plant polyphenols, saponins, flavonoids and the like, contains more than 400 nutrient substances, and has no toxic or side effect. Is rich in natural nutrients such as plant polysaccharide, plant polyphenol, total saponin, total flavone, plant pigment, caffeine, protein, vitamin B1, vitamin B2, vitamin C, vitamin E, folic acid, fatty acid, B-carotene, etc.; the health-care composition contains dozens of amino acids such as plant amino acid and threonine, is rich in various trace elements such as natural organic germanium (Ge), selenium (Se), molybdenum (Mo), zinc (Zn) and vanadium (V) which have important health-care effects on human bodies, and macro elements such as potassium (K), calcium (Ca) and magnesium (Mg). The main functional components and the functions of the medicine are as follows:
plant polysaccharide: the health composition is rich in polysaccharide. The polysaccharide can effectively control the postprandial blood sugar rise amplitude, improve the glucose tolerance, improve the lipid metabolism disorder and have obvious blood sugar reducing effect.
Plant polysaccharide polyphenols: the health composition is rich in tea polyphenols. The plant polyphenol can eliminate free radicals, and reduce the increase of DM blood sugar, thereby improving the sugar tolerance and stabilizing the blood sugar.
Total saponins: the health composition has total saponin content of 6300mg/kg, and has effects in tonifying heart, dilating blood vessel, relieving fatigue, slowing heart rate and bipolar blood pressure, promoting DNA, protein and lipid biosynthesis, quenching thirst, promoting salivation, expelling pus, relieving swelling, relieving sore throat, relieving pain, relieving fever, and relieving pain.
Total flavonoids: the health composition has total flavone content of 4400mg/kg, has effects in dilating coronary blood vessel, lowering hypertension, improving systole, reducing cardiac pulsation, quenching thirst, eliminating phlegm, resisting bacteria, relieving inflammation, resisting capillary fragility and abnormal permeability, resisting tumor, protecting liver, promoting gallbladder function, relieving spasm, relieving pain, reducing cholesterol, and promoting urination.
Plant pigment: the health composition contains abundant plant pigment, and has effects of reducing blood sugar, urine sugar, blood lipid, and glycosylated hemoglobin, reducing insulin resistance, improving blood rheology, and relieving microcirculation disturbance. Reducing cholesterol and triglyceride, and increasing high density lipoprotein, and can be used for preventing and treating DM complications, such as cardiovascular disease, cerebrovascular disease, and atherosclerosis.
Selenium (Se): the health composition contains selenium which is a component of glutathione in human erythrocytes, and has antioxidant, cell membrane protecting, and cardiovascular protecting effects. Scientists in China also find that selenium is an effective medicine for treating keshan disease and Kaschin-Beck disease, and in addition, selenium has a detoxifying function, reduces the toxicity of aflatoxin B1, has an attenuation effect on some chemical carcinogens, and can also reduce the damage of toxins to liver cells.
Germanium (Ge): the health composition contains germanium, and can reduce the biological potential of cancer cells, change their physiological state, inhibit proliferation and growth of cancer cells, induce interferon of anticancer substances in human body, and induce macrophage to become anticancer cells, so that it can be used for treating cancer. In addition, germanium also has obvious curative effect on angiosclerosis, cerebral thrombosis, cerebral hemorrhage, renal liver disease, gastropathy, diabetes, arthritis and chronic neuralgia.
Zinc (Zn): the health composition has zinc content of 283mg/kg and high zinc content. Zinc is associated with active enzymes in the human body, such as the important enzymes of carboxypeptidase enzymes to promote proteolysis in the intestinal tract, which contains zinc. Zinc has effects in stimulating appetite, promoting growth and development, promoting tissue regeneration, improving sexual function, enhancing immunity, enhancing resistance, and protecting vision.
Vanadium (V): is involved in the metabolism of lipids and cholesterol. It can promote hematopoiesis function and reduce blood plasma cholesterol obviously. The serum triglyceride of V-deficient animals is increased, and the cholesterol content is increased. The research shows that the total cholesterol beta-lipoprotein in the serum of the animals in the health-care composition group is obviously lower than that of the high-fat animal control group; serum total cholesterol: the health composition group is reduced by 35% compared with the high fat group; the content of clofibrate in the clofibrate group is reduced by 33.2 percent compared with that in the high fat group; β -lipoprotein: the health composition has high fat reduction of 36.6%; the content of manganese (Mn) in the clofibrate group is reduced by 23 percent compared with the high-fat group (the clofibrate is a globally accepted cholesterol and blood fat reducing agent): the content is high, and the trace elements are necessary for human bodies and participate in various enzymatic reactions. Can improve lipid metabolism of atherosclerosis patients. Preventing atherosclerosis. The incidence of arteriosclerosis is higher in the American population, and the concentrations of Mn, Cr and Cu in the aorta are less than those of Asia and Nonzea with lower incidence of arteriosclerosis and coronary heart disease.
Potassium (K): can maintain intracellular osmotic pressure and normal heart contraction.
Vitamin B1: the health composition is rich in vitamin B1, and has effects in preventing glycometabolism disorder, and maintaining normal functions of nervous system, digestive system and heart.
Vitamin B2: participate in the oxidation-reduction reaction of human body and maintain the normal mechanism of retina.
Vitamin C: the health composition is rich in vitamin C, and can maintain normal toughness and permeability of capillary, so that DM patients with fragile capillary can recover their normal functions by drinking tea.
Vitamin A: has effects in preventing nyctalopia and cataract, and resisting cancer.
Further, the plant health-care composition is a beverage.
The plant health-care composition prepared by the invention is directly added with boiled water with the temperature of 100 ℃ for brewing to obtain the beverage.
The second object of the present invention provides a preparation method of the plant health care composition, which comprises the following steps:
(1) weighing the raw materials in parts by weight respectively for later use;
(2) mixing the raw materials, and drying in layers, wherein the drying is carried out twice, the crushing treatment is carried out after the first drying, and then the second drying treatment is carried out, so as to obtain the plant health-care composition.
Further, the temperature of the first drying in the step (2) is more than 100 ℃, and the drying time is more than 1 h.
Further, the temperature for the first drying in the step (2) is 110-.
Further, the particle size of the pulverized particles in the step (2) is less than 5mm, and preferably, the particle size is 3-4 mm.
Further, the temperature of the second drying in the step (2) is more than 100 ℃, and the drying time is more than 30 min.
Further, the temperature of the second drying in the step (2) is 105-.
Compared with the prior art, the invention has the beneficial effects that:
(1) the health care composition has unique and magical effects on reducing blood sugar, blood pressure and blood fat, diabetes and complications thereof, and plays a role in synergistic balance regulation. The health care composition has obvious functions of reducing blood sugar and urine sugar and can effectively improve the three-high symptoms of diabetes. The health care composition can effectively reduce blood fat, improve various maladaptive symptoms caused by hypertension, reduce cholesterol and B-lipoprotein in serum, promote insulin secretion, enhance immunity, regulate blood flow, prevent atherosclerosis, resist bacteria, diminish inflammation, clear away heat and toxic materials, relieve constipation, promote diuresis, remove dampness, promote liver metabolism, prevent cancer, inhibit tumor growth and the like while effectively reducing blood sugar and blood pressure;
(2) the health care composition has simple preparation method and low production cost, and can be produced in a large scale.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the technical solutions of the present invention will be described in detail below. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the examples given herein without any inventive step, are within the scope of the present invention.
Example 1
A plant health composition comprises the following raw materials: 2g of wild ganoderma, 0.7g of ganoderma spore powder, 2g of ginseng under forest, 1.5g of pilose antler, 0.3g of saffron, 1.2g of cassia seed, 1g of medlar, 4g of pseudo-ginseng, 1g of gastrodia elata, 3g of dried orange peel, 0.8g of salvia miltiorrhiza, 4g of cordyceps sinensis, 2g of honeysuckle, 4g of bamboo leaf, 1g of ginseng flower, 4g of jasmine flower, 1g of lotus leaf, 3g of peach blossom, 1g of osmanthus fragrans, 3g of mulberry leaf, 2g of golden leaf, 5g of Liu' an Guapian, 4g of golden bud, 10g of Tieguanyin, 3g of Biluochun, 6g of Anji Maofeng, 4g of Longjing, 5g of Laoshan green tea, 6g of Gaoshan green tea, 5g of Houkui, 3g of pekoe green and 5 g.
The preparation method of the plant health care composition comprises the following steps:
(1) weighing the raw materials in parts by weight respectively for later use;
(2) mixing the raw materials, and drying in layers, wherein the drying is carried out twice, the crushing treatment is carried out after the first drying, the crushing particle size is 3mm, the temperature of the first drying is 110 ℃, the drying time is 1.5h, then the second drying treatment is carried out, the temperature of the second drying is 105 ℃, and the drying time is more than 50min, so as to obtain the plant health-care composition.
Example 2
A plant health composition comprises the following raw materials: 3g of wild ganoderma, 0.5g of ganoderma spore powder, 3g of ginseng under forest, 1g of pilose antler, 0.5g of saffron, 1g of cassia seed, 2g of wolfberry fruit, 3g of pseudo-ginseng, 2g of gastrodia elata, 2g of dried orange peel, 1g of salvia miltiorrhiza, 3g of cordyceps sinensis, 3g of honeysuckle, 3g of bamboo leaves, 2g of ginseng flowers, 3g of jasmine flowers, 2g of lotus leaves, 2g of peach blossom, 2g of sweet osmanthus, 2g of mulberry leaves, 3g of golden leaves, 4g of Liu' an melon slices, 5g of golden buds, 8g of Tieguanyin, 4g of Biluochun, 5g of Anji Maofeng, 5g of Longjing, 4g of Laoshan green tea, 8g of Gaoshan green tea, 4g of Houkui, 4g of Baihao green and 4g of.
The preparation method of the plant health care composition comprises the following steps:
(1) weighing the raw materials in parts by weight respectively for later use;
(2) mixing the raw materials, and drying in layers, wherein the drying is carried out twice, the crushing treatment is carried out after the first drying, the crushing particle size is 3.5mm, the temperature of the first drying is 115 ℃, the drying time is 1.75h, then the second drying treatment is carried out, the temperature of the second drying is 110 ℃, and the drying time is more than 45min, so as to obtain the plant health-care composition.
Example 3
A plant health composition comprises the following raw materials: 4g of wild ganoderma, 0.3g of ganoderma spore powder, 4g of ginseng under forest, 0.5g of pilose antler, 0.7g of saffron, 0.8g of cassia seed, 3g of wolfberry fruit, 2g of pseudo-ginseng, 3g of gastrodia elata, 1g of dried orange peel, 1.2g of salvia miltiorrhiza, 2g of cordyceps sinensis, 4g of honeysuckle, 2g of bamboo leaves, 3g of ginseng flowers, 2g of jasmine flowers, 3g of lotus leaves, 1g of peach blossom, 3g of sweet osmanthus, 1g of mulberry leaves, 4g of golden leaves, 3g of Liu' an Guapian, 6g of golden bud, 6g of Tieguanyin, 5g of Biluochun, 4g of Anji Maofeng, 6g of Longjing, 3g of Laoshan green tea, 10g of Gaoshan green tea, 3g of Houkui, 5g of pekoe and 3g of.
The preparation method of the plant health care composition comprises the following steps:
(1) weighing the raw materials in parts by weight respectively for later use;
(2) mixing the raw materials, and drying in layers, wherein the drying is carried out twice, the crushing treatment is carried out after the first drying, the crushing particle size is 4mm, the temperature of the first drying is 120 ℃, the drying time is 2h, then the second drying treatment is carried out, the temperature of the second drying is 115 ℃, and the drying time is more than 40min, so as to obtain the plant health-care composition.
Test example 1
The phytosanitary compositions prepared in examples 1 to 3 were administered to 300 persons who were aged 50 to 60 years and were equal to each other and had symptoms of hyperglycemia, hyperlipidemia and hypertension for 2 months, respectively, three times a day and 10g each time, and were taken with boiled water to examine the improvement of blood sugar, blood lipid and blood pressure, and the results are shown in table 1.
The method has the following advantages: blood sugar, blood fat and blood pressure are reduced uniformly and quantitatively;
and (4) invalidation: blood glucose, blood lipid and blood pressure were substantially unchanged or slightly changed.
TABLE 1
As can be seen from Table 1, the plant health care composition prepared by the invention has better effect of treating hypertension, hyperlipidemia and hyperglycemia.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (10)
1. A plant health composition is characterized by comprising the following raw materials: wild ganoderma lucidum, ganoderma lucidum spore powder, ginseng under forest, pilose antler, saffron, cassia seed, medlar, pseudo-ginseng, tall gastrodia tuber, tangerine peel, red-rooted salvia root, cordyceps sinensis, honeysuckle flower, bamboo leaf, ginseng flower, jasmine flower, lotus leaf, peach flower, sweet osmanthus flower, mulberry leaf, golden camellia, Liuan melon slice, golden bud, Tieguanyin, Biluochun, Anji Maofeng, Longjing, Laoshan green tea, Gaoshan green tea, Houkui, pekoe green and Xinyang Maojian.
2. The plant health composition according to claim 1, which is prepared from the following raw materials in parts by weight: 2-4 parts of wild ganoderma lucidum, 0.3-0.7 part of ganoderma lucidum spore powder, 2-4 parts of ginseng under forest, 0.5-1.5 parts of pilose antler, 0.3-0.7 part of saffron crocus, 0.8-1.2 parts of cassia seed, 1-3 parts of wolfberry fruit, 2-4 parts of pseudo-ginseng, 1-3 parts of gastrodia elata, 1-3 parts of dried orange peel, 0.8-1.2 parts of salvia miltiorrhiza, 2-4 parts of cordyceps sinensis, 2-4 parts of honeysuckle, 2-4 parts of bamboo leaves, 1-3 parts of ginseng flower, 2-4 parts of jasmine flower, 1-3 parts of lotus leaf, 1-3 parts of peach blossom, 1-3 parts of sweet osmanthus flower, 1-3 parts of mulberry leaf, 2-4 parts of golden leaf, 3-5 parts of Liuan melon slice, 4-6 parts of golden bud, 6-10 parts of Tieguanyin, 3-5 parts of Biluochun spring, 4-6 parts of Anji Maofeng, 4-6 parts of Longjing, 3-5 parts of Laoshan green tea, 6-10 parts of Gaoshan green tea, 3-5 parts of Houkui, 3-5 parts of pekoe and 3-5 parts of Xinyang Maojian tea.
3. The plant health composition according to claim 2, which is prepared from the following raw materials in parts by weight: 3 parts of wild ganoderma, 0.5 part of ganoderma spore powder, 3 parts of ginseng under forest, 1 part of pilose antler, 0.5 part of saffron, 1 part of cassia seed, 2 parts of wolfberry fruit, 3 parts of pseudo-ginseng, 2 parts of gastrodia elata, 2 parts of dried orange peel, 1 part of salvia miltiorrhiza, 3 parts of cordyceps sinensis, 3 parts of honeysuckle, 3 parts of bamboo leaves, 2 parts of ginseng flowers, 3 parts of jasmine flowers, 2 parts of lotus leaves, 2 parts of peach blossom, 2 parts of sweet osmanthus, 2 parts of mulberry leaves, 3 parts of golden leaves, 4 parts of Liu' an melon slices, 5 parts of golden buds, 8 parts of Tieguanyin, 4 parts of Biluochun, 5 parts of Anji Maofeng, 5 parts of Longjing, 4 parts of Laoshan green tea, 8 parts of Gaoshan green tea, 4 parts of Houkui, 4 parts of Baihao green and 4 parts of.
4. The phytosanitary composition according to any of claims 1 to 3, wherein said phytosanitary composition is a drink.
5. A method of preparing a phytosanitary composition according to any one of claims 1 to 4, comprising the steps of:
(1) weighing the raw materials in parts by weight respectively for later use;
(2) mixing the raw materials, and drying in layers, wherein the drying is carried out twice, the crushing treatment is carried out after the first drying, and then the second drying treatment is carried out, so as to obtain the plant health-care composition.
6. The method for preparing a plant health composition according to claim 5, wherein the temperature of the first drying in the step (2) is more than 100 ℃ and the drying time is more than 1 h.
7. The method for preparing a plant health composition as claimed in claim 6, wherein the temperature of the first drying in step (2) is 110-120 ℃ and the drying time is 1.5-2 h.
8. The method for preparing a phytosanitary composition according to claim 5, wherein the particle size crushed in step (2) is less than 5mm, preferably 3-4 mm.
9. The method for preparing a plant health composition according to claim 5, wherein the temperature of the second drying in the step (2) is more than 100 ℃ and the drying time is more than 30 min.
10. The method for preparing a plant health composition as claimed in claim 9, wherein the temperature of the second drying in step (2) is 105 ℃ and 115 ℃, and the drying time is more than 40-50 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010571503.XA CN111772185A (en) | 2020-06-22 | 2020-06-22 | Plant health-care composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010571503.XA CN111772185A (en) | 2020-06-22 | 2020-06-22 | Plant health-care composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111772185A true CN111772185A (en) | 2020-10-16 |
Family
ID=72756092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010571503.XA Pending CN111772185A (en) | 2020-06-22 | 2020-06-22 | Plant health-care composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111772185A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110165273A1 (en) * | 2008-09-05 | 2011-07-07 | Jiao Guo | A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid |
| CN104839655A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | High blood lipids, blood sugar and blood pressure lowering and yang tonifying medical formula food |
| CN106215012A (en) * | 2016-08-29 | 2016-12-14 | 广西康宝海美三高生态茶有限公司 | Prevention and treatment hypertension, hyperlipidemia, the teabag of hyperglycemia and processing method |
| CN107996757A (en) * | 2017-12-01 | 2018-05-08 | 贵州健瑞安药业有限公司 | A kind of blood pressure lowering, hypoglycemic, reducing blood lipid, the health beverages and preparation method thereof of norcholesterol |
-
2020
- 2020-06-22 CN CN202010571503.XA patent/CN111772185A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110165273A1 (en) * | 2008-09-05 | 2011-07-07 | Jiao Guo | A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid |
| CN104839655A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | High blood lipids, blood sugar and blood pressure lowering and yang tonifying medical formula food |
| CN106215012A (en) * | 2016-08-29 | 2016-12-14 | 广西康宝海美三高生态茶有限公司 | Prevention and treatment hypertension, hyperlipidemia, the teabag of hyperglycemia and processing method |
| CN107996757A (en) * | 2017-12-01 | 2018-05-08 | 贵州健瑞安药业有限公司 | A kind of blood pressure lowering, hypoglycemic, reducing blood lipid, the health beverages and preparation method thereof of norcholesterol |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105495244A (en) | Method for making shaddock, apple and tomato ferment health-care beverage | |
| CN102106580A (en) | Sobering-up and liver-protecting health beverage | |
| CN110201067B (en) | Ampelopsis grossedentata extract and preparation method and application thereof | |
| CN105581209A (en) | Preparation method of health-care grapefruit enzyme drink | |
| CN101375715A (en) | Nutrient powder made from chickpea and grape and preparation method thereof | |
| CN104055180A (en) | High-selenium-and-germanium enzyme beverage | |
| CN104431063A (en) | Leaf of strigose hydrangea functional beverage for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN101254011A (en) | Corn capillament drink and method of preparing the same | |
| CN110236059A (en) | Garbo fruit solid beverage and preparation method thereof | |
| CN106617049A (en) | Propolis healthcare product with moringa oleifera leaf extract and method for preparing propolis healthcare product | |
| CN109395028A (en) | A kind of Ge Jingjia ginseng wine formula and preparation method preventing, treating three high diseases | |
| KR101060308B1 (en) | Diabetic treatment or prevention composition comprising natural salt and nasturtium extract | |
| CN105831318A (en) | Polypeptide tea for blood glucose reduction and manufacturing method of polypeptide tea | |
| CN102599512B (en) | Sea buckthorn nutrition powder and preparation method thereof | |
| CN111772185A (en) | Plant health-care composition and preparation method thereof | |
| CN109043249A (en) | A kind of blueberry L-arabinose composite beverage underflow | |
| CN101982119B (en) | Mushroom multielement functional drink and preparation method thereof | |
| KR100677949B1 (en) | Diabetes functional beverage | |
| CN107384680A (en) | A kind of passion fruit longan witches' broom and its brewing method | |
| CN104206581A (en) | Aquilaria sinensis flower tea drink and preparation technology thereof | |
| CN106479848A (en) | A kind of Camellia nitidissima Chi Hawthorn Fruit Wine | |
| CN102613655A (en) | Gingko, garlic and broadleaf holly leaf compound particle drink | |
| CN105087285A (en) | Compound mulberry health wine and preparation method thereof | |
| CN104287008A (en) | Formula of plant drink | |
| KR102501329B1 (en) | Method for processing plum with improved anti-cancer activity, anti-diabetes activity and effectiveness in improving blood lipid and processed plum using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201016 |
|
| RJ01 | Rejection of invention patent application after publication |